Portfolio of Marijuana (Cannabis) Pharma Stocks Traded on OTC Markets

Here is a table of 7 OTC cannabis stocks that are developing cannabis compound medicines.

7 Cannabis Pharma Stocks - OTC Markets
Stock Returns & Price Chart	Symbol	Recent Prices & Annualized Return
Axim Biotechnologies	AXIM
Cannabics Pharmaceuticals	CNBX
GB Sciences	GBLX
OWC Pharmaceutical Research	OWCP
PharmaCyte Biotech	PMCB
United Cannabis	CNAB
Vitality Biopharma	VBIO
Price data from Quandl as of most recent close.

To inspect the performance of the Cannabis Pharma Stocks - OTC Markets portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Quandl.

All 7 stocks are included in the portfolio computations. The current value of the portfolio assumes that $1,428.57 was invested (total of $10,000) in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends.

The current value of a $10,000 investment is $1,443. The percent return is -85.57%. The annualized return is -63.58%.

Return Summary for Cannabis Pharma Stocks - OTC Markets
Start Date	Dec-31-2017
Start Investment	$10,000.00
End Date	Nov-30-2019
Current Value of Investment	$1,442.60
Total Return	-85.57%
Annualized Return	-63.58%
Min Date	Nov-30-2019
Min Price	$1,442.60
Max Date	Dec-31-2017
Max Price	$10,000.00
# Values	24
Number Returns	276
Number Profitable Returns	10
Percent Profitable Returns	3.62%
Number Unprofitable Returns	266
Percent Unprofitable Returns	96.38%
Profitable to Unprofitable Returns Ratio	0.04